Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells
- 12 March 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 315 (3) , 771-779
- https://doi.org/10.1016/j.bbrc.2004.01.118
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Phase III Trial of Fluorouracil, Interferon Alfa-2b, and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Metastatic or Unresectable Urothelial CancerJournal of Clinical Oncology, 2002
- Colchicine promotes a change in chromosome structure without loss of sister chromatid cohesion in prometaphase I-arrested bivalentsChromosoma, 2001
- Paclitaxel Is an Effective Antiproliferative Agent on the Human NCI-H295 Adrenocortical Carcinoma Cell LineChemotherapy, 1998
- Structure of the αβ tubulin dimer by electron crystallographyNature, 1998
- Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitroBritish Journal of Cancer, 1997
- THE DEVELOPMENT AND CLINICAL UTILITY OF THE TAXANE CLASS OF ANTIMICROTUBULE CHEMOTHERAPY AGENTSAnnual Review of Medicine, 1997
- Effects of taxol on the human NCI-H295 adrenocortical carcinoma cell lineEndocrine Research, 1996
- Paclitaxel-induced apoptosis in human gastric carcinoma cell linesCancer, 1996
- Differential Effect of Taxol in Rat Primary and Metastatic Prostate Tumors: Site-Dependent PharmacodynamicsPharmaceutical Research, 1996
- High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cellsBlood, 1993